These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mitochondrial response to controlled nutrition in health and disease. Schiff M; Bénit P; Coulibaly A; Loublier S; El-Khoury R; Rustin P Nutr Rev; 2011 Feb; 69(2):65-75. PubMed ID: 21294740 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of mitochondrial diseases. Ylikallio E; Suomalainen A Ann Med; 2012 Feb; 44(1):41-59. PubMed ID: 21806499 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784 [TBL] [Abstract][Full Text] [Related]
8. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Cordero MD; Cotán D; del-Pozo-Martín Y; Carrión AM; de Miguel M; Bullón P; Sánchez-Alcazar JA Nutrition; 2012; 28(11-12):1200-3. PubMed ID: 22898267 [TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087 [TBL] [Abstract][Full Text] [Related]
10. Nutritional cofactor treatment in mitochondrial disorders. Marriage B; Clandinin MT; Glerum DM J Am Diet Assoc; 2003 Aug; 103(8):1029-38. PubMed ID: 12891154 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction: a neglected component of skin diseases. Feichtinger RG; Sperl W; Bauer JW; Kofler B Exp Dermatol; 2014 Sep; 23(9):607-14. PubMed ID: 24980550 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Wu YT; Wu SB; Lee WY; Wei YH Ann N Y Acad Sci; 2010 Jul; 1201():147-56. PubMed ID: 20649551 [TBL] [Abstract][Full Text] [Related]
14. [Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status]. Menke T Georgian Med News; 2008 Mar; (156):24-32. PubMed ID: 18403806 [TBL] [Abstract][Full Text] [Related]
15. Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients. Moreno-Fernández AM; Cordero MD; Garrido-Maraver J; Alcocer-Gómez E; Casas-Barquero N; Carmona-López MI; Sánchez-Alcázar JA; de Miguel M J Psychiatr Res; 2012 Mar; 46(3):341-5. PubMed ID: 22118833 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial disorders. Zeviani M; Carelli V Curr Opin Neurol; 2007 Oct; 20(5):564-71. PubMed ID: 17885446 [TBL] [Abstract][Full Text] [Related]
17. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I. Plecitá-Hlavatá L; Jezek J; Jezek P Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311 [TBL] [Abstract][Full Text] [Related]
18. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Orsucci D; Filosto M; Siciliano G; Mancuso M Nutr Rev; 2009 Aug; 67(8):427-38. PubMed ID: 19674340 [TBL] [Abstract][Full Text] [Related]
19. [Mitochondrial diseases--a new branch of the modern medicine]. Zagoskin PP; Khvatova EM Vopr Med Khim; 2002; 48(4):321-36. PubMed ID: 12506607 [TBL] [Abstract][Full Text] [Related]